These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33412929)

  • 21. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Zhang FS; He QZ; Qin CH; Little PJ; Weng JP; Xu SW
    Acta Pharmacol Sin; 2022 Sep; 43(9):2173-2190. PubMed ID: 35046517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.
    Wang L; Peng Y; Song L; Xia D; Li C; Li Z; Li Q; Yu A; Lu C; Wang Y
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1075-1089. PubMed ID: 34436706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Something old, something new: a paradigm for considering immune therapies for cardiovascular disease.
    Weber BN; Blankstein R
    Cardiovasc Res; 2020 Apr; 116(5):e51-e53. PubMed ID: 32215658
    [No Abstract]   [Full Text] [Related]  

  • 24. Colchicine in Atherosclerotic Vascular Disease: The Good, the Bad, and the Ugly.
    Tuvali O; Sella G; Haberman D; Cuciuc V; George J
    Isr Med Assoc J; 2022 Mar; 24(3):191-197. PubMed ID: 35347935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is There a Role for Colchicine in Acute Coronary Syndromes?
    Nidorf SM; Verma S
    J Am Heart Assoc; 2015 Aug; 4(8):e002372. PubMed ID: 26304942
    [No Abstract]   [Full Text] [Related]  

  • 26. [Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].
    Klingenberg R; Nitschmann S
    Internist (Berl); 2020 Jul; 61(7):766-769. PubMed ID: 32103281
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G
    Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod.
    Kragholm K; Newby LK; Melloni C
    Drug Des Devel Ther; 2015; 9():4279-86. PubMed ID: 26273189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine for prevention of cardiovascular events.
    Hemkens LG; Ewald H; Gloy VL; Arpagaus A; Olu KK; Nidorf M; Glinz D; Nordmann AJ; Briel M
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011047. PubMed ID: 26816301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory drugs as promising cardiovascular treatments.
    Huet F; Akodad M; Fauconnier J; Lacampagne A; Roubille F
    Expert Rev Cardiovasc Ther; 2017 Feb; 15(2):109-125. PubMed ID: 28010154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine.
    Barraclough JY; Joglekar MV; Januszewski AS; Martínez G; Celermajer DS; Keech AC; Hardikar AA; Patel S
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):444-455. PubMed ID: 32356454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.
    Bosch X; Marrugat J; Sanchis J
    Cochrane Database Syst Rev; 2013 Oct; (10):CD002130. PubMed ID: 24136036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colchicine in ischemic heart disease: the good, the bad and the ugly.
    D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F
    Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.
    Bosch X; Marrugat J; Sanchis J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002130. PubMed ID: 24203004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.